Isamu Sugiura

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed <i>BCR</i>-<i>ABL</i>–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura et al. · Journal of Clinical Oncology · 2005 · 454 citations · Full text

Medicine, Hematology, Oncology +15

Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study

Shigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki et al. · Clinical Infectious Diseases · 2015 · 149 citations · Full text

Medicine, Hematology, Oncology +15

Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11

Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta et al. · Blood Advances · 2020 · 127 citations · Full text

Medicine, Hematology, Oncology +15

Prospective monitoring of <i>BCR‐ABL1</i> transcript levels in patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia undergoing imatinib‐combined chemotherapy

Masamitsu Yanada, Isamu Sugiura, Jin Takeuchi et al. · British Journal of Haematology · 2008 · 101 citations · Full text

Medicine, Hematology, Oncology +17

High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG

Toru Sakura, Fumihiko Hayakawa, Isamu Sugiura et al. · Leukemia · 2017 · 79 citations

Medicine, Oncology, Pharmacology +7